Tempo Therapeutics Inc — SBIR/STTR Competitive Profile
Aggregate SBIR/STTR award history for Tempo Therapeutics Inc, built entirely from public federal award records. Free competitive intelligence — no login required.
- 5 awards
- $5,629,145 total on record
- 2 agencies
- 2 Phase I · 3 Phase II
Phase mix
- Phase I — 2 awards
- Phase II — 3 awards
Funding agencies
Awards by year
- 2023 — 1 award
- 2021 — 1 award
- 2020 — 1 award
- 2019 — 1 award
- 2016 — 1 award
Places of performance
Firms like Tempo Therapeutics Inc
See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.
Sign in to see firms like this
The full similar-firms list is free with an account. Sign in or create a free account to compare competitors.
Recent awards
| Award | Agency | Amount | Program | Start |
|---|---|---|---|---|
| 2308751 | National Science Foundation | $1,000,000 | STTR · Phase II | 2023-06-15 |
| 1R44DK130778-01 | Department of Health and Human Services | $2,549,496 | SBIR · Phase II | 2021-09-15 |
| 2031727 | National Science Foundation | $255,998 | SBIR · Phase I | 2020-09-01 |
| 1R44DK124085-01 | Department of Health and Human Services | $1,598,652 | SBIR · Phase II | 2019-09-15 |
| 1R43DK109843-01 | Department of Health and Human Services | $224,999 | SBIR · Phase I | 2016-09-16 |
Frequently asked questions
How many SBIR/STTR awards has Tempo Therapeutics Inc won?
Tempo Therapeutics Inc has won 5 SBIR/STTR awards worth $5,629,145 in the public federal award records SBIR Signal tracks, including 2 Phase I and 3 Phase II award(s).
Which agencies fund Tempo Therapeutics Inc?
Tempo Therapeutics Inc's awards come from 2 agencies on record; its top funder is Department of Health and Human Services.
What technology areas does Tempo Therapeutics Inc work in?
Based on its award history, Tempo Therapeutics Inc works in a range of technology areas.
How do I find firms similar to Tempo Therapeutics Inc?
Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.